[263 Pages Report] As per the Future Market Insights’ latest industry analysis, the global ligament augmentation market is set to grow from US$ 41.0 Mn in 2021 to US$ 76.3 Mn by 2032, expanding at a CAGR of 5.8% over the forecast period. One of the body’s strongest ligaments, the anterior cruciate ligament (ACL) in the knee, is frequently the target of traumatic …
Category Archives: Healthcare Trends
Humanized Mouse Model is projected to grow at a 5.5% CAGR to reach US$ 167.3 Million | FMI
[300 Pages Report] In 2022, the global humanised mouse model market is expected to be worth US$ 92.5 million. During the decade 2022-2032, the industry is expected to grow at a 5.5% CAGR to reach US$ 167.3 Million. The use of genetically engineered mice in experimental medical research have led to significant advances to understand the disease …
Genitourinary Prosthetics Market is expected to accumulate US$ 556.0 Million in value by 2022-end
Prosthesis, in general is an artificial medical device that is used to replace any missing part that might have lost during trauma, congenital conditions or infectious disease. Prosthetist or a team of healthcare experts commonly including surgeons, physical therapists, psychiatrists, and occupational therapists coordinate with each other to offer smooth services in prosthetic amputee rehabilitation. …
Kaempferol Market is anticipated to be valued at US$ 5.79 billion by 2032 | FMI
[342 Pages Report] The kaempferol market, which was valued at US$ 3.91 billion in 2022, is expected to grow at a CAGR of 4% during the forecast period, reaching US$ 5.79 billion by 2032. Kaempferol provides excellent benefits like reducing the risk of chronic diseases like cancer, strengthening anti-oxidant defense against free radicals, offering resistance against …
Continue reading “Kaempferol Market is anticipated to be valued at US$ 5.79 billion by 2032 | FMI”
Advanced Infusion Systems Market is likely to be valued at US$ 8,470.25 Mn in 2022 and is predicted to secure a slow-paced CAGR of 6.4% from 2022 – 2033
[306 Pages Report] The global advanced infusion systems market is likely to be valued at US$ 8,470.25 million in 2022 and is predicted to secure a slow-paced CAGR of 6.4% during the forecast period. The market is expected to grow at a value of US$ 15,820.03 million by 2032. Infusion systems are medical instruments and associated …
Transcranial Doppler Ultrasounds System Market is likely to reach a revenue of about US$ 658.4 million by 2032 | FMI
[333 Pages Report] With a projected CAGR of 7.4% from 2022 to 2032, the global transcranial doppler ultrasounds system market is anticipated to generate around US$ 658.4 million in sales, up from US$ 299.2 million in 2022. Transcranial doppler ultrasounds system are medically used for quantitative measurement of blood flow velocity of the brain vessels. Transcranial …
3D Medical Implants Market to be valued at US$ 2,494.5 Mn by 2032 | FMI
The three-dimensional (3D) medical implants are medical devices that offer aids in the medical reconstruction procedures of physical faults and abnormalities of the body. The 3D medical implants are commonly additively manufactured using 3D printers; which allow to develop complex geometry features and customized implants specific to the patients’ anatomy. The 3D medical implants technology integrates virtual …
Continue reading “3D Medical Implants Market to be valued at US$ 2,494.5 Mn by 2032 | FMI”
Nasal Packing Devices Market is projected to be valued at about US$ 299.35 Mn by 2032 | FMI
[342 Pages Report] The global nasal packing devices market is expected to reach a market valuation of US$ 182.03 Million by the year 2022, accelerating with a moderate CAGR of 5.1% by 2022-2032. Nasal Packing Devices market size is anticipated to be valued at about US$ 299.35 Million by 2032 end. With more people experiencing epistaxis, there has been …
Autoimmune Disease Therapeutics Market is likely to be valued at US$ 68,410.54 million in 2022 | FMI
[308 Pages Report] Autoimmune Disease Therapeutics Market: Drivers and Restraints Factors contributing to the growth of global autoimmune disease therapeutics market includes, growing prevalence of autoimmune diseases coupled with growing public awareness and increasing automation of laboratories leading to diagnosis of several diagnostic tests simultaneously to generate rapid and error free results. In addition, technological advancements such …
Antisense Oligonucleotides Market is estimated to amass revenue of around US$ 5,659.2 Mn by 2032
[306 Pages Report] The global antisense oligonucleotides market is projected to amass revenue of around US$ 5,659.2 million by 2032, up from US$ 1,921.6 million in 2022 moving forward with a CAGR of 10.3% during the forecast period. Antisense Oligonucleotides market players – Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited among others represent the global Antisense Oligonucleotides market. …